Semaglutide (GLP-1) targets appetite control and metabolic benefits, while Tirzepatide offers enhanced results through its dual GLP-1 + GIP action
Adibekian, Alexander
[19] If substantial weight regain occurs despite intensive lifestyle efforts, resuming Zepbound or trying alternative pharmacotherapy may be medically appropriate, as obesity is a chronic, relapsing condition
If a sponsor wants to focus on muscle volume assessments, MRI offers more muscle-related endpoints, while DXA can assess fat and lean mass parameters
It is not an FDA approved medication, but it is made in pharmacies that are FDA approved and regulated
When combined with testosterone, watch for changes in blood pressure, lipid abnormalities, or worsening fatigue